German-developed cancer vaccine expected by 2030

The Turkish-German BioNTech founders Uğur Şahin and Özlem Türeci have announced that a vaccine to target cancer cells could be ready for patients by 2030.

Related Keywords

Germany ,Turkey ,German , ,Uğur Şahin ,Özlem Türeci ,Biontech Cancer Vaccine ,Cancer Cures ,Cancer Treatment Advancements ,Cancer Vaccine Germany ,Vaccine Advances ,Cancer Treatment Germany ,Bowel Cancer Treatment ,Mrna Molecule ,Vaccine Research Germany ,Cancer Cells Vaccine ,2030 Cancer Cure ,